ENLIVEX THERAPEUTICS LTD.

Insiders Enlivex Therapeutics Ltd.

Equities

ENLV

IL0011319527

Market Closed - Nasdaq Other stock markets 04:30:00 2024-07-11 pm EDT			5-day change	1st Jan Change
1.42 ^USD	+1.43%		+5.97%	-47.41%

Jun. 30	Enlivex Therapeutics Ltd.'s Equity Buyback announced on August 30, 2023 has expired.	CI
Jun. 24	Enlivex Therapeutics Says First Patient Dosed in Phase 1/2 Thumb Osteoarthritis Trial	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Enlivex Therapeutics Ltd. Appoints Andrew Singer to Its Board of Directors	23-04-17	CI
MediWound Appoints COO	22-06-30	MT
Enlivex Therapeutics Ltd. Announces Appointment of Roger J. Pomerantz to its Board of Directors as Vice Chairman	22-05-24	CI
Enlivex Therapeutics Ltd. Appoints Roger J. Pomerantz to Its Board of Directors as Vice Chairman	22-05-23	CI
Enlivex Appoints Dr. Brian Schwartz to the Board of Directors	20-11-17	CI
Enlivex Therapeutics Ltd. Announces Executive Changes	20-05-19	CI
Enlivex Therapeutics Ltd. Announces the Appointment of Oren Hershkovitz as Chief Executive Officer, Effective November 16, 2019	19-10-24	CI
Enlivex Therapeutics Ltd. Announces Management Changes	19-09-30	CI
Bioblast Pharma Ltd. and Enlivex Therapeutics Ltd. Announce Management Changes	18-11-19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Secure my Investments

fermer